Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a6399d236ec0ea3dc12007c4c82740e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 |
filingDate |
1980-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c39f7add0e0eda3b70f65121cc04c84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c043fbe7e7bdf0d90a433b3506ec3933 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2513cd11f412c1a1a3f5156dde010d0 |
publicationDate |
1981-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0024842-A1 |
titleOfInvention |
Methyl (5-(2-thienylhydroxymethyl)-1H-benzimidazol-2-yl) carbamate, process for its preparation and compositions containing it |
abstract |
Methyl [5-(2-thienythydroxymethyl)-1H-benzimi- dazol-2-yl]carbamate is a potent antimitotic agent. It can be prepared by reduction of methyl [5-(2-thenoyl)-1 H-benzimidazol-2-yl]carbamate. The invention also provides antimitotic compositions containing the compound of the invention. |
priorityDate |
1979-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |